Jörn D. Beck

2.8k total citations
71 papers, 1.8k citations indexed

About

Jörn D. Beck is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Jörn D. Beck has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Public Health, Environmental and Occupational Health, 19 papers in Pediatrics, Perinatology and Child Health and 16 papers in Molecular Biology. Recurrent topics in Jörn D. Beck's work include Childhood Cancer Survivors' Quality of Life (18 papers), Acute Lymphoblastic Leukemia research (17 papers) and Glioma Diagnosis and Treatment (7 papers). Jörn D. Beck is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (18 papers), Acute Lymphoblastic Leukemia research (17 papers) and Glioma Diagnosis and Treatment (7 papers). Jörn D. Beck collaborates with scholars based in Germany, United States and Austria. Jörn D. Beck's co-authors include Thorsten Langer, Wolfgang Stöhr, Thorsten Langer, Stefan Bielack, Johann Greil, Rolf Marschalek, H. Jürgens, Marios Paulides, Holger Hertzberg and W Meier and has published in prestigious journals such as Nucleic Acids Research, Cancer and Oncogene.

In The Last Decade

Jörn D. Beck

69 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörn D. Beck Germany 22 490 489 482 411 375 71 1.8k
Alexander Aledo United States 10 244 0.5× 660 1.3× 354 0.7× 327 0.8× 547 1.5× 15 1.5k
Herbert E. Fuchs United States 27 431 0.9× 574 1.2× 304 0.6× 309 0.8× 188 0.5× 90 2.3k
Xavier Rialland France 23 514 1.0× 490 1.0× 212 0.4× 384 0.9× 198 0.5× 45 1.6k
Hyeon Jin Park South Korea 19 358 0.7× 223 0.5× 305 0.6× 219 0.5× 155 0.4× 92 1.6k
Martin Champagne Canada 25 832 1.7× 288 0.6× 300 0.6× 231 0.6× 855 2.3× 59 2.5k
J Ochs United States 24 205 0.4× 852 1.7× 278 0.6× 450 1.1× 490 1.3× 36 1.6k
Mathias Schmid Germany 24 704 1.4× 301 0.6× 183 0.4× 161 0.4× 807 2.2× 86 2.0k
Juan Ortega Spain 20 395 0.8× 449 0.9× 290 0.6× 392 1.0× 1.6k 4.3× 67 2.5k
Andrew W. Walter United States 25 825 1.7× 622 1.3× 569 1.2× 544 1.3× 152 0.4× 54 2.6k
Anne Uyttebroeck Belgium 27 469 1.0× 776 1.6× 517 1.1× 662 1.6× 402 1.1× 132 2.7k

Countries citing papers authored by Jörn D. Beck

Since Specialization
Citations

This map shows the geographic impact of Jörn D. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörn D. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörn D. Beck more than expected).

Fields of papers citing papers by Jörn D. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörn D. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörn D. Beck. The network helps show where Jörn D. Beck may publish in the future.

Co-authorship network of co-authors of Jörn D. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Jörn D. Beck. A scholar is included among the top collaborators of Jörn D. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörn D. Beck. Jörn D. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, Jörn D., Carsten Bokemeyer, & Thor s ten Langer. (2020). Late Treatment Effects and Cancer Survivor Care in the Young. 6 indexed citations
2.
Thomas, Carys, Jörn D. Beck, Christine C. Krieger, et al.. (2015). Haematopoietic toxicity of radium-223 in patients with high skeletal tumour burden. Nuklearmedizin - NuclearMedicine. 54(5). 197–203. 15 indexed citations
3.
Paulides, Marios, et al.. (2009). Late Effects Surveillance System After Childhood Cancer in Germany, Austria and Parts of Switzerland – Update 2009. Strahlentherapie und Onkologie. 185(S2). 5–7. 8 indexed citations
4.
Paulides, Marios, et al.. (2009). Nachsorge von Patienten mit Krebs im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde. 157(4). 329–338. 2 indexed citations
5.
Stieglmaier, Julia, Christian Kellner, Matthias Peipp, et al.. (2007). A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells. Leukemia. 21(7). 1405–1412. 23 indexed citations
6.
Stöhr, Wolfgang, Marios Paulides, Stefan Bielack, et al.. (2006). Ifosfamide‐induced nephrotoxicity in 593 sarcoma patients: A report from the Late Effects Surveillance System. Pediatric Blood & Cancer. 48(4). 447–452. 76 indexed citations
7.
Völkl, Thomas M.K., Thorsten Langer, Thomas Aigner, et al.. (2006). Klinefelter syndrome and mediastinal germ cell tumors. American Journal of Medical Genetics Part A. 140A(5). 471–481. 47 indexed citations
8.
Langer, Thor s ten, Wolfgang Stöhr, Stefan Bielack, et al.. (2003). Late effects surveillance system for sarcoma patients. Pediatric Blood & Cancer. 42(4). 373–379. 41 indexed citations
9.
Langer, Thor s ten, Monika Führer, Yvonne Dörffel, et al.. (2002). Die Überlebenden einer Krebserkrankung im Kindesalter Nachsorge und Spätfolgen nach erfolgreicher Therapie. Monatsschrift Kinderheilkunde. 150(8). 942–953. 3 indexed citations
10.
Haupt, Riccardo, E. Frey, Herwig Lackner, et al.. (2002). ELTEC: Ten years of activity (1990–2000)—A report of the International BFM Study Group. Medical and Pediatric Oncology. 38(2). 124–124. 2 indexed citations
11.
Calaminus, Gabriele, Thor s ten Langer, Normann Willich, & Jörn D. Beck. (2000). Lebensqualität und Spätfolgen bei Kindern und Jugendlichen mit Krebserkrankungen. Der Onkologe. 6(9). 868–877. 3 indexed citations
12.
Marx, M., Jörn D. Beck, Gerhard G. Grabenbauer, & Rudolf Fahlbusch. (2000). Gonadotrophin-Independent Puberty in a Boy with a β-HCG-Secreting Brain Tumour. Hormone Research in Paediatrics. 54(1). 44–48. 4 indexed citations
13.
14.
Siegler, Gabriele Margareta, et al.. (1996). A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias.. PubMed. 56(9). 2171–7. 38 indexed citations
15.
Siegler, Gabriele Margareta, et al.. (1996). Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. British Journal of Haematology. 93(4). 966–972. 112 indexed citations
16.
Ueberall, Michael A., Holger Hertzberg, Thorsten Langer, et al.. (1996). Quantitative EEG in long-term survivors of acute lymphoblastic leukemia. Pediatric Neurology. 15(4). 293–298. 9 indexed citations
17.
Marschalek, Rolf, et al.. (1995). Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;ll). British Journal of Haematology. 90(2). 308–320. 24 indexed citations
18.
Sailer, R., et al.. (1993). Verbrauchskoagulopathie durch pränatale Einblutungen in ein kongenitales mesoblastisches Nephrom. Fallbericht. Klinische Pädiatrie. 205(3). 176–179. 4 indexed citations
19.
Morgan, A., et al.. (1983). The advantages and limitations of an in vivo test system for investigating the cytotoxicity and fibrogenicity of fibrous dusts.. Environmental Health Perspectives. 51. 267–273. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Aledo Breakdown of academic impact, for papers by Herbert E. Fuchs Breakdown of academic impact, for papers by Xavier Rialland Breakdown of academic impact, for papers by Hyeon Jin Park Breakdown of academic impact, for papers by Martin Champagne Breakdown of academic impact, for papers by J Ochs Breakdown of academic impact, for papers by Mathias Schmid Breakdown of academic impact, for papers by Juan Ortega Breakdown of academic impact, for papers by Andrew W. Walter Breakdown of academic impact, for papers by Anne Uyttebroeck
Rankless by CCL
2026